There is increasing evidence for an autoimmune aetiology in post-infectious Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). SARS-CoV-2 has now become the …

Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severely
debilitating condition which markedly restricts activity and function of affected people. Since …

Abstract Introduction Following SARS‐CoV‐2‐infection up to 21% of patients will develop
post‐COVID‐syndrome. Autoantibodies (AAbs) targeting neuronal‐ß‐adrenergic and …

Most patients with Post COVID Syndrome (PCS) present with a plethora of symptoms without
clear evidence of organ dysfunction. A subset of them fulfills diagnostic criteria of myalgic …

Methods A total of ten patients received five immunoadsorption treatments (within ten days)
on an inpatient basis. Inclusion criteria comprised confirmed fatigue-dominant long-/post …

Introduction Infection-triggered disease onset, chronic immune activation and autonomic
dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) point to an …

As millions of patients have been infected by SARS-CoV-2 virus a vast number of individuals
complain about continuing breathlessness and fatigue even months after the onset of the …

Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic
disease considered to be triggered by viral infections in a majority of cases. Symptoms …

The findings of controlled trials on use of intravenous immunoglobulin G (IV IgG) to treat
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are generally viewed as …

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic
disease of unknown etiology, sharing a similar clinical presentation with the increasingly …